Research Article

Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naïve Type 2 Diabetes Patients: A Randomized Placebo Controlled Study

Table 1

Baseline clinical and laboratory characteristics of MO leaf and placebo group.

MO leaf
Placebo
value

Male sex7 (44%)10 (56%)0.48
Age (years)0.07
Body weight (kg)0.91
BMI (kg/m2)0.14
Duration of DM (months)18 (1–48)18 (2–60)0.72
Family history of DM14 (88%)12 (75%)0.65
Hypertension7 (44%)10 (63%)0.29
Antihypertensive agents (%)7 (22%) 9 (28%)1.00
Dyslipidemia9 (56%)13 (81%)0.13
Lipid lowering agents (%)5 (16%)11 (34%)0.28
FPG (mg/dl)0.14
HbA1C (%)0.39

MO leaf, Moringa oleifera leaf; BMI, body mass index; DM, diabetes mellitus; FPG, fasting plasma glucose; HbA1C, hemoglobin A1C.